# Maximus, Inc.: Form 10-Q for the period ended Jun 30, 2022

- Company: [Maximus, Inc.](/companies/mms.md) (CIK 1032220)
- Form: 10-Q
- Filed: 2022-08-04
- Accepted by EDGAR: Aug 4, 2022, 17:07 ET
- Period: 2022-06-30
- Accession: 0001032220-22-000046
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1032220/000103222022000046/mms-20220630.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1032220/000103222022000046/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2022-04-01 to 2022-06-30 | $1.13bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2021-10-01 to 2022-06-30 | $3.45bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2022-04-01 to 2022-06-30 | $915.6m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months, 2021-10-01 to 2022-06-30 | $2.79bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2022-04-01 to 2022-06-30 | $210.2m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2021-10-01 to 2022-06-30 | $666.8m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2022-04-01 to 2022-06-30 | $133.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2021-10-01 to 2022-06-30 | $387.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2022-04-01 to 2022-06-30 | $54.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2021-10-01 to 2022-06-30 | $211.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2022-04-01 to 2022-06-30 | $9.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2021-10-01 to 2022-06-30 | $44.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2022-04-01 to 2022-06-30 | $31.3m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2021-10-01 to 2022-06-30 | $134.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2022-04-01 to 2022-06-30 | $0.51 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2021-10-01 to 2022-06-30 | $2.17 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2022-04-01 to 2022-06-30 | $0.51 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2021-10-01 to 2022-06-30 | $2.17 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2022-04-01 to 2022-06-30 | 61,756,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2021-10-01 to 2022-06-30 | 62,190,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2021-10-01 to 2022-06-30 | $169.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2021-10-01 to 2022-06-30 | $35.9m | us-gaap:PaymentsToAcquireProductiveAssets |
| Share repurchases | 9 months, 2021-10-01 to 2022-06-30 | $73.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2022-06-30 | $93.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2022-06-30 | $1.07bn | us-gaap:AssetsCurrent |
| Total assets | at 2022-06-30 | $4.06bn | us-gaap:Assets |
| Current liabilities | at 2022-06-30 | $730.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2022-06-30 | $2.54bn | us-gaap:Liabilities |
| Long-term debt | at 2022-06-30 | $1.42bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2022-06-30 | $59.7m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2022-06-30 | $1.52bn | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |

## Management's discussion and analysis

As filed, 37,544 characters.

*The following discussion is intended to help the reader understand our business, financial condition, results of operations, liquidity and capital resources. You should read this discussion in conjunction with "Risk Factors," "Forward-Looking Statements," and our financial statements and related notes included in our Annual Report on Form 10-K for fiscal year 2021 filed with the Securities and Exchange Commission on November 18, 2021 (the "2021 Form 10-K") and elsewhere in this Quarterly Report on Form 10-Q, as applicable.*

### Business Overview

We are a leading operator of government health and human services programs worldwide. We use our experience, business process management expertise, innovation, and technology solutions to help government agencies run effective, efficient, and accountable programs. Our customers include civilian agencies of governments worldwide, including those at federal, national, state and local levels.

Over the past five years, we have executed a three-pronged growth strategy: we have evolved through our digital transformation to meet the modernization needs of our clients; we have expanded our clinical assessment capabilities to meet growing demand for independent and conflict-free clinical services; and we have expanded our markets, both organically and through acquisitions.

We experienced both favorable and unfavorable impacts as a result of the Coronavirus ("COVID-19") global pandemic. While some of the programs we support have experienced reduced volumes due to the pandemic, we have also been successful in winning new contracts to meet the immediate needs of our customers, including contact tracing and disease investigation, vaccine information lines, and unemployment insurance administration. Demonstrating the value of our business model, we have converted a number of these relationships into longer-term contract opportunities. The individuals and families served under these programs are those considered some of the most vulnerable to COVID-19. As a result, we believe our operations support programs that are vital for their safety and wellbeing.

In 2022, we underwent a strategy refresh which focused on leveraging our successful foundation and strong technology portfolio to create the strategic focus for the next three to five years.

- Customer Services, Digitally Enabled. We will elevate the customer experience to achieve higher levels of satisfaction, performance, and outcomes through intelligent automation and cognitive computing. This strategy builds on our success and focuses on those capabilities and technologies most relevant to the future of citizen interactions with government programs.
- Future of Health. We are continuing our focus of clinical evolution by helping governments meet rising demand for health services. We will do this by growing our clinical capabilities to improve the health of people and their communities.
- Advanced Technologies for Modernization. We will leverage our deep relationships and programmatic knowledge to further our credibility as a technology leader enabling the transformation of government programs to be resilient, dynamic, integrated, and equitable.

Governments around the world need help meeting the rising demand for health services and to be able to do so in a manner that provides higher levels of customer satisfaction, performance and outcomes through the use of technology. Through our focus on health, customer services and technology, we look to partner with governments to respond to complex challenges they face in delivering their largest and most critical programs.

### Financial Overview

A number of factors have affected our results for the third quarter of fiscal year 2022, the most significant of which we have listed below. More detail on these changes is presented below within our "Results of Operations" section.

- During fiscal year 2021, we acquired VES Group, Inc. ("VES"), the Federal Division of Attain, LLC ("Attain") and Connect Assist Holdings Limited ("Connect Assist"). During fiscal year 2022, we acquired the student loan servicing business from Navient, rebranded as Aidvantage, BZ Bodies Limited ("BZB"), and Stirling Institute of Australia Pty Ltd ("Stirling"). From the date of each acquisition, we have received the benefit of additional revenue, as well as additional operating costs. In completing these acquisitions, we have allocated a portion of each purchase price to identifiable intangible assets, which we are amortizing over the estimated useful lives of each asset.
- To fund the acquisition of VES, we entered into a new credit facility comprised of fixed term debt and a new revolving credit facility. The cost of servicing this debt, as well as the cost of the debt facilities, has resulted in an increase in our interest expense.
- Our services in fiscal years 2022 and 2021 were affected by the COVID-19 pandemic. We received the benefit from new, short-term work, assisting governments with their responses to the pandemic, which was often highly profitable. This mitigated the effect of declines in established programs where our transaction volume has been reduced. Many of our core Medicaid programs are anticipated to continue operating at reduced levels due to the ongoing Public Health Emergency. As a condition of receiving supplemental funding under the PHE, those programs are required to pause eligibility redetermination. This has resulted in a revenue decline, and an outsized profit impact, where our contracts are compensated based on volumes of transactions.
- In our OUS Segment, we recorded a charge of $11.7 million on a single project, anticipating a loss over the life of the contract. If our current forecast remains unchanged, this project should record a breakeven profit for the remainder of its life.

### Results of Operations

*Table MD&A 1: Consolidated Results of Operations*

*(dollars in thousands, except per share data)*

|  | For the Three Months Ended June 30, 2022 | June 30, 2021 | For the Nine Months Ended June 30, 2022 | June 30, 2021 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $1,125,785 | $1,243,520 | $3,453,987 | $3,148,354 |
| Cost of revenue | 915,564 | 951,664 | 2,787,160 | 2,419,785 |
| Gross profit | 210,221 | 291,856 | 666,827 | 728,569 |
| **Gross profit percentage** | **18.7%** | **23.5%** | **19.3 %** | **23.1 %** |
| Selling, general, and administrative expenses | 132,974 | 140,129 | 387,502 | 364,498 |
| **Selling, general, and administrative expenses as a percentage of revenue** | **11.8%** | **11.3%** | **11.2 %** | **11.6 %** |
| Amortization of intangible assets | 22,690 | 12,132 | 67,951 | 23,718 |
| Operating income | 54,557 | 139,595 | 211,374 | 340,353 |
| **Operating income margin** | **4.8%** | **11.2%** | **6.1 %** | **10.8 %** |
| Interest expense | (10,791) | (3,087) | (29,867) | (4,049) |
| Other expense, net | (2,497) | (8,289) | (2,093) | (9,584) |
| Income before income taxes | 41,269 | 128,219 | 179,414 | 326,720 |
| Provision for income taxes | 9,934 | 33,724 | 44,653 | 87,534 |
| **Effective tax rate** | **24.1%** | **26.3%** | **24.9 %** | **26.8 %** |
| Net income | $31,335 | $94,495 | $134,761 | $239,186 |
| Earnings per share: |  |  |  |  |
| Basic | $0.51 | $1.52 | $2.17 | $3.86 |
| Diluted | $0.51 | $1.51 | $2.17 | $3.84 |

25

Our business segments have different factors driving revenue fluctuations and profitability. The sections that follow cover these segments in greater detail. Our revenue reflects fees earned for services provided. Cost of revenue consists of direct costs related to labor and related overhead, subcontractor labor, outside vendors, rent, and other direct costs. The largest component of cost of revenue, approximately two-thirds, is labor, including subcontracted labor.

*Table MD&A 2: Changes in Revenue, Cost of Revenue, and Gross Profit for the Three Months Ended June 30, 2022*

*(dollars in thousands)*

|  | Revenue Dollars | % Change | Cost of Revenue Dollars | % Change | Gross Profit Dollars | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Three Months Ended June 30, 2021 | $1,243,520 |  | $951,664 |  | $291,856 |  |
| Organic effect | (251,277) | (20.2)% | (137,342) | (14.4)% | (113,935) | (39.0)% |
| Acquired growth | 150,217 | 12.1% | 116,490 | 12.2% | 33,727 | 11.6% |
| Currency effect compared to the prior period | (16,675) | (1.3)% | (15,248) | (1.6)% | (1,427) | (0.5)% |
| Three Months Ended June 30, 2022 | $1,125,785 | (9.5)% | $915,564 | (3.8)% | $210,221 | (28.0)% |

*Table MD&A 3: Changes in Revenue, Cost of Revenue, and Gross Profit for the Nine Months Ended June 30, 2022*

*(dollars in thousands)*

|  | Revenue Dollars | % Change | Cost of Revenue Dollars | % Change | Gross Profit Dollars | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Nine Months Ended June 30, 2021 | $3,148,354 |  | $2,419,785 |  | $728,569 |  |
| Organic effect | (279,979) | (8.9)% | (67,612) | (2.8)% | (212,367) | (29.1)% |
| Acquired growth | 606,410 | 19.3% | 452,782 | 18.7% | 153,628 | 21.1% |
| Currency effect compared to the prior period | (20,798) | (0.7)% | (17,795) | (0.7)% | (3,003) | (0.4)% |
| Nine Months Ended June 30, 2022 | $3,453,987 | 9.7% | $2,787,160 | 15.2% | $666,827 | (8.5)% |

#### Selling, General and Administrative

Selling, general, and administrative expenses ("SG&A") consists of indirect costs related to general management, marketing, and administration. It is primarily composed of labor costs. These costs may be incurred at a segment level, for dedicated resources that are not client-facing, or at a corporate level. Corporate costs are allocated to segments on a consistent and rational basis. Fluctuations in our SG&A are primarily driven by changes in our administrative cost base, which is not directly driven by changes in our revenue. As part of our work for the U.S. federal government and many states, we allocate these costs using a methodology driven by the U.S. Federal Cost Accounting Standards. Our SG&A expense increased year-over-year primarily due to the additional cost base from our acquisitions.

#### Amortization of Intangible Assets

Our amortization of intangible assets increased by $10.6 million and $44.2 million for the three and nine months ended June 30, 2022, compared to same periods ended June 30, 2021. The increase is a result of acquisitions during fiscal years 2021 and 2022. This increase is partially offset by the intangible asset amortization related to the Census Questionnaire Assistance (CQA) contract, which was fully amortized through November 2020.

*Table MD&A 4: Changes in Amortization of Intangible Assets Expense for Three and Nine Months Ended June 30, 2022*

*(dollars in thousands)*

|  | For the Three Months Ended June 30, 2022 Dollars | For the Nine Months Ended June 30, 2022 Dollars |
| --- | ---: | ---: |
| Period Ending June 30, 2021 | $12,132 | $23,718 |
| VES acquisition | 9,249 | 36,916 |
| Attain acquisition | — | 4,375 |
| Aidvantage acquisition | 1,858 | 5,574 |
| Other 2022 acquisitions | 296 | 609 |
| CQA contract | — | (2,313) |
| Other, including foreign exchange | (845) | (928) |
| Period Ending June 30, 2022 | $22,690 | $67,951 |

*Table MD&A 5: Non-GAAP Adjusted Results Excluding Amortization of Intangible Assets*

*(dollars in thousands, except per share data)*

|  | For the Three Months Ended June 30, 2022 | June 30, 2021 | For the Nine Months Ended June 30, 2022 | June 30, 2021 |
| --- | ---: | ---: | ---: | ---: |
| Operating income | $54,557 | $139,595 | $211,374 | $340,353 |
| Add back: Amortization of intangible assets | 22,690 | 12,132 | 67,951 | 23,718 |
| Adjusted operating income excluding amortization of intangible assets (Non-GAAP) | $77,247 | $151,727 | $279,325 | $364,071 |
| Adjusted operating income margin excluding amortization of intangible assets (Non-GAAP) | 6.9% | 12.2% | 8.1% | 11.6% |
| Net income | $31,335 | $94,495 | $134,761 | $239,186 |
| Add back: Amortization of intangible assets, net of tax | 16,750 | 8,941 | 50,164 | 17,364 |
| Adjusted net income excluding amortization of intangible assets (Non-GAAP) | $48,085 | $103,436 | $184,925 | $256,550 |
| Diluted earnings per share | $0.51 | $1.51 | $2.17 | $3.84 |
| Add back: Effect of amortization of intangible assets on diluted earnings per share | 0.27 | 0.15 | 0.80 | 0.28 |
| Adjusted diluted earnings per share excluding amortization of intangible assets (Non-GAAP) | $0.78 | $1.66 | $2.97 | $4.12 |

Our intangible asset amortization is based upon our assumptions of the value and economic life, typically established at the acquisition date. If these assumptions change, the pattern of future expense may be accelerated. At this time, we have a significant asset related to the Customer Center Operations (CCO) contract which is subject to a rebid anticipated towards the end of this fiscal year. If this rebid is unsuccessful, the asset life of this asset may need to be reduced.

#### Interest Expense

Interest expense for the three months ended June 30, 2022, increased by $7.7 million to $10.8 million, while interest expense for the nine months ended June 30, 2022, increased by $25.8 million to $29.9 million. This increase is driven by the costs of our cash borrowings utilized to acquire VES. Interest expense is expected to be about $42 million for fiscal year 2022 as the debt is expected to be outstanding for the entire fiscal year. Our interest rate will vary based upon both prevailing interest rates and our leverage ratio.

#### Provision for Income Taxes

Our effective income tax rate for the three and nine months ended June 30, 2022, was 24.1% and 24.9%, respectively, compared to 26.3% and 26.8% for the three and nine months ended June 30, 2021. For fiscal year 2022, we expect the effective tax rate to be between 25.0% and 25.5%.

### U.S. Services Segment

Our U.S. Services Segment provides a variety of business process services ("BPS") such as program administration, appeals and assessments, and related consulting work for U.S. state and local government programs. These services support a variety of programs, including the Affordable Care Act ("ACA"), Medicaid, the Children's Health Insurance Program ("CHIP"), Temporary Assistance to Needy Families ("TANF"), and child support programs. Addressing societal macro trends such as aging populations and rising costs, the segment continues to execute on its clinical evolution strategy by expanding its clinical offerings. This includes assessments to determine whether personal care services are medically necessary and public health offerings such as contact tracing, disease investigation, and vaccine distribution support services as part of the governments' COVID-19 response efforts.

*Table MD&A 6: U.S. Services Segment - Financial Results*

*(dollars in thousands)*

|  | For the Three Months Ended June 30, 2022 | June 30, 2021 | For the Nine Months Ended June 30, 2022 | June 30, 2021 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $399,320 | $436,338 | $1,183,814 | $1,269,487 |
| Cost of revenue | 325,185 | 331,524 | 935,009 | 946,231 |
| Gross profit | 74,135 | 104,814 | 248,805 | 323,256 |
| Selling, general, and administrative expenses | 42,351 | 42,606 | 115,726 | 116,655 |
| Operating income | 31,784 | 62,208 | 133,079 | 206,601 |
| Gross profit percentage | 18.6 % | 24.0 % | 21.0% | 25.5% |
| Operating margin percentage | 8.0 % | 14.3 % | 11.2% | 16.3% |

Our revenue and cost of revenue for the three months ended June 30, 2022, decreased 8.5% and 1.9%, compared to three months ended June 30, 2021, respectively. For the nine months ended June 30, 2022, our revenue and cost of revenue decreased 6.7% and 1.2%, respectively. All movement was organic.

For the three months ended June 30, 2021, we received $164 million of short-term COVID-19 related work, typically at higher margins. For the three months ended June 30, 2022, COVID-19 related work provided $24 million of revenue. As a result, both revenue and profit margins have decreased year-over-year. Conversely, we are still awaiting the return of many of our core programs to pre-pandemic levels of operation, in particular those where we are paid based upon the volume of redetermination activities. The Federal public health emergency declaration has been extended through mid-October which will further delay the commencement of redeterminations. Accordingly, we do not expect recoveries in these contracts until fiscal year 2023. For the full fiscal year, we anticipate an operating margin between 10% and 11%.

### U.S. Federal Services Segment

From technology solutions to program administration and operations, our U.S. Federal Services Segment delivers end-to-end solutions that help various U.S. federal government agencies better deliver on their mission. This also includes appeals and assessments services, system and application development, IT modernization, and maintenance services. The segment also contains certain state-based assessments and appeals work that is part of the segment's heritage within the Medicare Appeals portfolio which continues to be managed within this segment. Benefiting from the Maximus Federal Consulting (formerly Attain Federal) platform, the segment executes on its digital strategy to deliver technology solutions that advance agency missions, including the challenge to modernize, provide better customer experience, and drive process efficiencies. The segment continues to expand its clinical solutions with the acquisition of VES which manages the clinical evaluation process for U.S. veterans and service members on behalf of the U.S. Department of Veterans Affairs. The segment further supports clinical offerings in public health with new work supporting the U.S. federal government's COVID-19 response efforts. This included expanded work with the Centers for Disease Control and Prevention ("CDC") for their helpline and increased support for the IRS Wage and Investment Division's response efforts to general inquiries regarding the Coronavirus Aid Relief & Economic Security ("CARES") Act and Economic Impact Payment Service Plan.

*Table MD&A 7: U.S. Federal Services Segment - Financial Results*

*(dollars in thousands)*

|  | For the Three Months Ended June 30, 2022 | June 30, 2021 | For the Nine Months Ended June 30, 2022 | June 30, 2021 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $525,519 | $617,601 | $1,680,678 | $1,352,982 |
| Cost of revenue | 401,316 | 461,825 | 1,314,746 | 1,040,577 |
| Gross profit | 124,203 | 155,776 | 365,932 | 312,405 |
| Selling, general, and administrative expenses | 69,466 | 69,647 | 203,340 | 172,877 |
| Operating income | 54,737 | 86,129 | 162,592 | 139,528 |
| Gross profit percentage | 23.6% | 25.2% | 21.8% | 23.1% |
| Operating margin percentage | 10.4% | 13.9% | 9.7% | 10.3% |

*Table MD&A 8: U.S. Federal Services Segment - Changes in Revenue, Cost of Revenue, and Gross Profit for the Three Months Ended June 30, 2022*

*(dollars in thousands)*

|  | Revenue Amount | % Change | Cost of Revenue Amount | % Change | Gross Profit Amount | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Three Months Ended June 30, 2021 | $617,601 |  | $461,825 |  | $155,776 |  |
| Organic effect | (235,221) | (38.1)% | (172,738) | (37.4)% | (62,483) | (40.1)% |
| Acquired growth | 143,139 | 23.2% | 112,229 | 24.3% | 30,910 | 19.8% |
| Three Months Ended June 30, 2022 | $525,519 | (14.9)% | $401,316 | (13.1)% | $124,203 | (20.3)% |

*Table MD&A 9: U.S. Federal Services Segment - Changes in Revenue, Cost of Revenue, and Gross Profit for the Nine Months Ended June 30, 2022*

*(dollars in thousands)*

|  | Revenue Amount | % Change | Cost of Revenue Amount | % Change | Gross Profit Amount | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Nine Months Ended June 30, 2021 | $1,352,982 |  | $1,040,577 |  | $312,405 |  |
| Organic effect | (259,527) | (19.2)% | (167,028) | (16.1)% | (92,499) | (29.6)% |
| Acquired growth | 587,223 | 43.4% | 441,197 | 42.4% | 146,026 | 46.7% |
| Nine Months Ended June 30, 2022 | $1,680,678 | 24.2% | $1,314,746 | 26.3% | $365,932 | 17.1% |

Our results for the three months ended June 30, 2022 received the benefit of growth from VES, which we acquired in May 2021, and Aidvantage, which we acquired in October 2021. Our year-to-date results also include the benefit of the Attain acquisition, which was completed in March 2021.

The decline in our organic business is driven by a small number of large, pandemic-related contracts which ended in late 2021 or early 2022. These contracts resulted in approximately $24 million and $280 million of revenue for the three months ended June 30, 2022 and 2021, respectively. This short-term work was typically at higher margins than our standard services. We have also accepted a lower return on an existing contract in return for increased funding and anticipated future revenue.

Following a loss in the second quarter, Aidvantage returned to profitability in the three months ended June 30, 2022. This has improved our quarterly margins but still acts as a detriment on our margins over the first nine months of the year.

We anticipate operating margins between 10% and 11% for the full fiscal year. These margins will be tempered by an expected $8 million to $10 million of additional costs as we staff up VES to address additional volumes in fiscal year 2023.

### Outside the U.S. Segment

Our Outside the U.S. Segment provides BPS for international governments and commercial clients, transforming the lives of people around the world. Helping people find employment, access vital support, and remain healthy, these services include health and disability assessments, program administration for employment services, wellbeing solutions, and other job seeker related services. We support programs and deliver services in the U.K., including the Health Assessment Advisory Service ("HAAS") and Restart; Australia, including Workforce Australia and the Disability Employment Service; Canada, including Health Insurance British Columbia and the Employment Program of British Columbia; in addition to

Italy, Saudi Arabia, Singapore, South Korea, and Sweden, where we predominantly provide employment support and job seeker services.

*Table MD&A 10: Outside the U.S. Segment - Financial Results*

*(dollars in thousands)*

|  | For the Three Months Ended June 30, 2022 | June 30, 2021 | For the Nine Months Ended June 30, 2022 | June 30, 2021 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $200,946 | $189,581 | $589,495 | $525,885 |
| Cost of revenue | 189,063 | 158,315 | 537,405 | 432,977 |
| Gross profit | 11,883 | 31,266 | 52,090 | 92,908 |
| Selling, general, and administrative expenses | 23,101 | 22,973 | 68,452 | 65,018 |
| Operating income/(loss) | (11,218) | 8,293 | (16,362) | 27,890 |
| Gross profit percentage | 5.9% | 16.5% | 8.8% | 17.7% |
| Operating margin percentage | (5.6)% | 4.4% | (2.8)% | 5.3% |

*Table MD&A 11: Outside the U.S. Segment - Changes in Revenue, Cost of Revenue, and Gross Profit for the Three Months Ended June 30, 2022*

*(dollars in thousands)*

|  | Revenue Amount | % Change | Cost of Revenue Amount | % Change | Gross Profit Amount | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Three Months Ended June 30, 2021 | $189,581 |  | $158,315 |  | $31,266 |  |
| Organic effect | 20,962 | 11.1% | 41,735 | 26.4% | (20,773) | (66.4)% |
| Acquired growth | 7,078 | 3.7% | 4,261 | 2.7% | 2,817 | 9.0% |
| Currency effect compared to the prior period | (16,675) | (8.8)% | (15,248) | (9.6)% | (1,427) | (4.6)% |
| Three Months Ended June 30, 2022 | $200,946 | 6.0% | $189,063 | 19.4% | $11,883 | (62.0)% |

*Table MD&A 12: Outside the U.S. Segment - Changes in Revenue, Cost of Revenue, and Gross Profit for the Nine Months Ended June 30, 2022*

*(dollars in thousands)*

|  | Revenue Amount | % Change | Cost of Revenue Amount | % Change | Gross Profit Amount | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Nine Months Ended June 30, 2021 | $525,885 |  | $432,977 |  | $92,908 |  |
| Organic effect | 65,221 | 12.4% | 110,638 | 25.6% | (45,417) | (48.9)% |
| Acquired growth | 19,187 | 3.6% | 11,585 | 2.7% | 7,602 | 8.2% |
| Currency effect compared to the prior period | $(20,798) | (4.0)% | $(17,795) | (4.1)% | (3,003) | (3.2)% |
| Nine Months Ended June 30, 2022 | $589,495 | 12.1% | $537,405 | 24.1% | $52,090 | (43.9)% |

This segment experienced organic growth in revenue and costs, as well as acquired growth, during the three and nine months ended June 30, 2022. These were mitigated by declines in the values of the currencies in which we operate against the U.S. Dollar.

Fiscal year 2022 has seen revenue and cost growth from our United Kingdom business, where the Restart contract continued to ramp up. Whereas results in fiscal year 2021 included a significant revenue benefit from the recovery of our welfare-to-work contracts in Australia, this contract ended in June 2022 and we were awarded a significantly lower caseload for the follow-on contract. This resulted in reduced revenues for the three months ended June 30, 2022, as well as costs related to the ramping down of our existing case load, including severance. Profit margins were also tempered by a charge of $11.7 million related to a single large modernization contract. We anticipate that we will record a loss for this segment in the current fiscal year.

Acquired growth is from the Stirling, Connect Assist and BZB acquisitions.

Much of our revenue, including that on the Restart contract, stems from our employment services contracts. On many contracts, we recognize revenue based upon estimates of future employment outcomes, which have become more volatile due to the effects of the COVID-19 pandemic, including those actions adopted by governments and employers. We update our estimates regularly based upon actual performance and updated expectations, but a sudden change in employment markets may result in significant fluctuations in our revenue.

### Liquidity and Capital Resources

Our primary sources of liquidity are cash on hand, cash flows from operating activities, and availability under our credit facilities, including our $600 million revolving credit facility. As of June 30, 2022, we had $93.7 million in cash and cash equivalents. We believe that our current cash position, access to our credit facility, and cash flows generated from operations should be not only sufficient for our operating requirements but also to enable us to fund share repurchases and any required long-term debt payments through the next several fiscal years. See Note 7 to the Consolidated Financial Statements for a more detailed discussion of our debt financing arrangements.

*Table MD&A 13: Net Change in Cash and Cash Equivalents and Restricted Cash*

*(in thousands)*

|  | For the Nine Months Ended June 30, 2022 | June 30, 2021 |
| --- | ---: | ---: |
| Net cash provided by operating activities | 169,776 | 246,659 |
| Net cash used in investing activities | (48,080) | (1,811,606) |
| Net cash (used in)/provided by financing activities | (163,272) | 1,586,792 |
| Effect of foreign exchange rates on cash and cash equivalents and restricted cash | (4,369) | 2,830 |
| Net change in cash and cash equivalents and restricted cash | $(45,945) | $24,675 |

#### Net Cash Provided By Operating Activities

Net cash provided by operating activities decreased by $76.9 million for the nine months ended June 30, 2022, compared to nine months ended June 30, 2021. This decrease is primarily caused by the decline in operating income and increased interest payments related to our credit facility.

Our Days Sales Outstanding ("DSO") as of June 30, 2022, and September 30, 2021, were 70 days and 68 days, respectively. Approximately $80 million of outstanding receivables were collected in the first two business days of July.

#### Net Cash Used In Investing Activities

The net cash used in investing activities was $48.1 million for the nine months ended June 30, 2022. In addition to capital expenditures, we made payments to acquire BZB and Stirling, as well as a final payment for the acquisition of VES. The prior year comparative total includes payments for the acquisitions of VES and Attain.

#### Net Cash (Used In)/Provided By Financing Activities

The $163.3 million cash used in financing activities during the nine months ended June 30, 2022, includes $73.9 million for share repurchases, $51.8 million in dividend payments and $9.7 million in tax withholding payments for stock awards. We have made $28.0 million of net repayments of debt related to the mandatory repayments on our U.S. credit facility and a mix of mandatory and voluntary payments related to our subsidiary debt. The prior year cash inflows include the proceeds from our new Credit Facility.

With the acquisition of Aidvantage, we have incurred a liability to the seller based upon future performance, which we have estimated at $16.4 million. We expect these payments to be made through fiscal year 2024.

### Cash in Foreign Locations

We have no requirement to remit funds from our foreign locations to the U.S. We will continue to explore opportunities to remit additional funds, taking into consideration the working capital requirements and relevant tax rules in each jurisdiction. When we are unable to remit funds back without incurring a penalty, we will consider these funds indefinitely reinvested until such time as these restrictions are changed. As a result, we do not record U.S. deferred income taxes on any funds held in foreign jurisdictions. We have not attempted to calculate our potential liability from any transfer of these funds as any such transaction might include tax planning strategies that we have not fully explored. Accordingly, it is not possible to estimate the potential tax obligations if we were to remit all of our funds from foreign locations to the U.S.

### Free Cash Flow (Non-GAAP)

*Table MD&A 14: Free Cash Flow (Non-GAAP)*

*(in thousands)*

|  | For the Nine Months Ended June 30, 2022 | June 30, 2021 |
| --- | ---: | ---: |
| Net cash provided by operating activities | $169,776 | $246,659 |
| Purchases of property and equipment and capitalized software | (35,936) | (32,133) |
| Free cash flow (Non-GAAP) | $133,840 | $214,526 |

### Critical Accounting Policies and Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires us to make estimates, judgments, and assumptions that affect the amounts reported. Actual results could differ from those estimates. The 2021 Form 10-K, as filed with the SEC on November 18, 2021, includes a summary of critical accounting policies we believe are the most important to aid in understanding our financial results. There have been no changes to those critical accounting policies that have had a material impact on our reported amounts of assets, liabilities, revenues, or expenses during the nine months ended June 30, 2022.

### Non-GAAP and Other Measures

We utilize non-GAAP measures where we believe it will assist users of our financial statements in understanding our business. The presentation of these measures is meant to complement, but not replace, other financial measures in this document. The presentation of non-GAAP numbers is not meant to be considered in isolation, nor as an alternative to revenue growth, cash flows from operating activities, net income, or earnings per share as measures of performance. These non-GAAP measures, as determined and presented by us, may not be comparable to related or similarly titled measures presented by other companies.

For the nine months ended June 30, 2022, 17% of our revenue was generated outside the U.S. We believe that users of our financial statements wish to understand the performance of our foreign operations using a methodology which excludes the effect of year-over-year exchange rate fluctuations. To calculate year-over-year currency movement, we determine the current fiscal year's results for all foreign businesses using the exchange rates in the prior fiscal year. We refer to this adjusted revenue on a "constant currency basis."

In recent years, we have made a number of acquisitions. We believe users of our financial statements wish to evaluate the performance of our operations, excluding changes that have arisen due to businesses acquired or disposed of. We identify acquired revenue and cost of revenue by showing these results for periods for which no comparative results exist within our financial statements. We identify revenue and cost of revenue that has been disposed of in a similar manner. This information is supplemented by our calculations of organic growth. To calculate organic growth, we compare current fiscal year results excluding results from acquisitions or disposals, to our prior fiscal year results.

Our recent acquisitions have resulted in significant intangible assets which are amortized over their estimated useful lives. We believe users of our financial statements wish to understand the performance of the business by using a methodology that allows them to compare operating activities excluding the effects of the amortization of intangible assets. Accordingly, we have calculated our operating profit, net income, and earnings per share excluding the effect of the amortization of intangible assets. We have included a table showing our reconciliation of these income measures to their corresponding GAAP measures.

In order to sustain our cash flows from operations, we regularly refresh our fixed assets and technology. We believe that users of our financial statements wish to understand the cash flows that directly correspond with our operations and the investments we must make in those operations using a methodology which combines operating cash flows and capital expenditures. We provide free cash flow to complement our statement of cash flows. Free cash flow shows the effects of the Company's operations and replacement capital expenditures and excludes the cash flow effects of acquisitions, purchases of our common stock, dividend payments, and other financing transactions. We have provided a reconciliation of cash flows from operating activities to free cash flow in "Liquidity and Capital Resources."

To sustain our operations, our principal source of financing comes from receiving payments from our customers. We believe that users of our financial statements wish to evaluate our efficiency in converting revenue into cash receipts. Accordingly, we provide DSO, which we calculate by dividing billed and unbilled receivable balances at the end of each quarter by revenue per day for the period. Revenue per day for a quarter is determined by dividing total revenue by 91 days.

As noted above, we have a $2.10 billion corporate credit facility. Our credit agreement includes the defined term Consolidated EBITDA and our calculation of Adjusted EBITDA conforms to the credit agreement definition. We believe our investors appreciate the opportunity to understand the possible restrictions which arise from our credit agreement.

- Adjusted EBITDA is also a useful measure of performance which focuses on the cash generating capacity of the business as it excludes the non-cash expenses of depreciation and amortization, and makes for easier comparisons between the operating performance of companies with different capital structures by excluding interest expense and therefore the impacts of financing costs.
- The measure of Adjusted EBITA is a step in calculating Adjusted EBITDA and facilitates comparisons to similar businesses as it isolates the amortization effect of business combinations.
- Our corporate credit facility requires us to calculate Adjusted EBITDA on a pro forma basis, as though we had owned any significant acquired business for a full twelve months. Accordingly, we have included pro forma data for VES, Aidvantage, Connect Assist, BZB and Stirling in the table below. Our corporate credit facility also allows other adjustments to Adjusted EBITDA for the purposes of calculating our leverage ratio, including anticipated synergies from acquisitions and one-time costs.

We have provided a reconciliation from net income to Non-GAAP Adjusted EBITA, Non-GAAP Adjusted EBITDA, and Non-GAAP Pro Forma Adjusted EBITDA as shown below.

*Table MD&A 15: Reconciliation of Net Income to Non-GAAP Adjusted EBITA, Non-GAAP Adjusted EBITDA, and Non-GAAP Pro Forma Adjusted EBITDA*

*(in thousands)*

|  | For the Three Months Ended June 30, 2022 | For the Trailing Twelve Months Ended June 30, 2022 |
| --- | ---: | ---: |
| Net income | $31,335 | $186,774 |
| Adjustments: |  |  |
| Interest expense | 10,791 | 40,562 |
| Other expense, net | 2,497 | 2,614 |
| Provision for income taxes | 9,934 | 49,601 |
| Amortization of intangibles | 22,690 | 88,590 |
| Stock compensation expense | 7,028 | 29,810 |
| Acquisition-related expenses | (1,957) | 1,501 |
| Adjusted EBITA - Non-GAAP measure | 82,318 | 399,452 |
| Depreciation and amortization of property, equipment, and capitalized software | 8,676 | 42,572 |
| Adjusted EBITDA - Non-GAAP measure | 90,994 | 442,024 |
| Pro forma adjusted EBITDA related to acquisitions - Non-GAAP measure | — | 8,709 |
| Other pro forma adjustments permitted by our debt agreement | $23,163 | $38,272 |
| Pro forma adjusted EBITDA - Non-GAAP measure | $114,157 | $489,005 |

33

## Market risk

As filed, 512 characters.

In the normal course of business, we are exposed to financial risks such as changes in interest rates, foreign currency exchange rates, and counterparty risk. We use derivative instruments to manage selected interest rate exposures. The Company's market rate risk disclosures set forth in Part II, Item 7A, "Quantitative and Qualitative Disclosures About Market Risk" on the 2021 Form 10-K, as filed with the SEC on November 18, 2021, have not changed materially during the nine month period ended June 30, 2022.

## Controls and procedures

As filed, 1,794 characters.

Management's Evaluation of Disclosure Controls and Procedures. The Company maintains disclosure controls and procedures designed to ensure that information required to be disclosed in its periodic filings under the Securities Exchange Act of 1934 ("Exchange Act"), including this Quarterly Report on Form 10-Q, is recorded, processed, summarized, and reported on a timely basis. These disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed under the Exchange Act is accumulated and communicated to the Company's management on a timely basis to allow decisions about required disclosure. Management, including the Company's Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the design and operation of Maximus' disclosure controls and procedures (as defined under Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of June 30, 2022.

Maximus carried out the evaluation of the effectiveness of its disclosure controls and procedures, required by paragraph (b) of Exchange Act Rules 13a-15 and 15d-15, under the supervision and with the participation of management, including the Chief Executive Officer and Chief Financial Officer. Based upon this evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company's disclosure controls and procedures were effective as of June 30, 2022.

Changes in Internal Control Over Financial Reporting. There were no changes in the Company's internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) during the three months ended June 30, 2022, that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

## Risk factors

As filed, 182 characters.

There were no material changes during the nine months ended June 30, 2022, to the risk factors previously disclosed in the 2021 Form 10-K, as filed with the SEC on November 18, 2021.

Filed Aug 4, 2022.
Source: SEC EDGAR, the filing index for accession 0001032220-22-000046. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.
